Radiobiology and Molecular Oncology: How are they Changing Radiotherapy in Clinical Practice?

ICTR 2009: 4th International Conference on Translational Research and Preclinical Strategies in Radiation Oncology. Radiother Oncol, 90: s1–126, 2009.

Yu C.X. , Amies C.J. , Svatos M. : Planning and delivery of intensity-modulated radiation therapy. Med Phys, 35: 5233–5241, 2008.

Welsh J.S. : Basics of particle therapy: introduction to hadrons. Am J Clin Oncol, 31: 493–495, 2008.

O'Neill P. , Wardman P. : Radiation chemistry comes before radiation biology. Int J Radiat Biol, 85: 9–25, 2009.

Meyn R.E. , Milas L. , Ang K. : The role of apoptosis in radiation oncology. Int J Radiat Biol, 85: 107–115, 2009.

Baumann M. , Krause M. , Hill R. : Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer, 8: 545–554, 2008.

Robson T. , Hirst D.G. : Themed issue: radiation biology-can new concepts achieve better treatment outcomes? J Pharm Pharmacol, 60: 1243–1245, 2008.

Grégoire V. , Haustermans K. , Geets X. , Roels S. , Lonneux M. : PET-based treatment planning in radiotherapy: a new standard? J Nucl Med, 48 (Suppl 1): 68S–77S, 2007.

Busk M. , Horsman M.R. , Overgaard J. : Resolution in PET hypoxia imaging: voxel size matters. Acta Oncol, 47: 1201–1210, 2008.

Bentzen S.M. : Dose painting and theragnostic imaging: towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology. Cancer Treat Res, 139: 41–62, 2008.

Deasy J.O. , El Naqa I. : Image-based modeling of normal tissue complication probability for radiation therapy. Cancer Treat Res, 139: 215–256, 2008.

Valdagni R. , Rancati T. , Ghilotti M. , Cozzarini C. , Vavassori V. , Fellin G. , Fiorino C. , Girelli G. , Barra S. , Zaffaroni N. , Pierotti M.A. , Gariboldi M. : To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys, 2009; 74: 1431–1440.

Azria D. , Ozsahin M. , Kramar A. , Peters S. , Atencio D.P. , Crompton N.E. , Mornex F. , Pèlegrin A. , Dubois J.B. , Mirimanoff R.O. , Rosenstein B.S. : Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res, 14: 6284–6288, 2008.

Borgmann K. , Hoeller U. , Nowack S. , Bernhard M. , Röper B. , Brackrock S. , Petersen C. , Szymczak S. , Ziegler A. , Feyer P. , Alberti W. , Dikomey E. : Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy. Int J Radiat Oncol Biol Phys, 71: 256–264, 2008.

Brizel DM J. : Pharmacologic approaches to radiation protection. Clin Oncol, 25: 4084–4089, 2007.

Quanz M. , Berthault N. , Roulin C. , Roy M. , Herbette A. , Agrario C. , Alberti C. , Josserand V. , Coll J.L. , Sastre-Garau X. , Cosset J.M. , Larue L. , Sun J.S. , Dutreix M. : Small-molecule drugs mimicking DNA damage: a new strategy for sensitizing tumors to radiotherapy. Clin Cancer Res, 15: 1308–1316, 2009.

Shannon A.M. , Williams K.J. : Antiangiogenics and radiotherapy. J Pharm Pharmacol, 60: 1029–1036, 2008.

Juzenas P. , Chen W. , Sun Y.P. , Coelho M.A. , Generalov R. , Generalova N. , Christensen I.L. : Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv Drug Deliv Rev, 60: 1600–1614, 2008.